Home ➤ Life Science ➤ Therapeutics ➤ RNA Based Therapeutic Market
RNA Based Therapeutic Market
Published date: June 2025 • Formats:
Request Sample Schedule a Call

RNA Based Therapeutic Market By Type (RNA Interference (RNAi) technologies, RNA Antisense, Purification, Labeling, and Inhibition), By Application (Genetic Disorders, Oncology, Metabolic Disorders, Infectious Diseases, and Auto-immune Disorders), By End-user (Research Institutes, Hospitals & Clinics), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: June 2025
  • Report ID: 151331
  • Number of Pages: 312
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key RNA Based Therapeutic Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of RNA Based Therapeutic Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global RNA Based Therapeutic Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 3.3. Global RNA Based Therapeutic Market Attractiveness Analysis, By Type
        • 3.3.1. RNA Antisense
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. RNA Interference (RNAi) Technologies
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Purification
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Labeling
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
        • 3.3.5. Inhibition
          • 3.3.5.1. Insights
          • 3.3.5.2. Key Takeaways
      • 3.4. Global RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.5. Global RNA Based Therapeutic Market Attractiveness Analysis, By Application
        • 3.5.1. Genetic Disorders
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Oncology
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Metabolic Disorders
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Infectious Diseases
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
        • 3.5.5. Auto-immune Disorders
          • 3.5.5.1. Insights
          • 3.5.5.2. Key Takeaways
      • 3.6. Global RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.7. Global RNA Based Therapeutic Market Attractiveness Analysis, By End-user
        • 3.7.1. Research Institutes
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Hospitals & Clinics
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
    • 4. Global RNA Based Therapeutic Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global RNA Based Therapeutic Market Attractiveness Analysis, By Region
    • 5. North America RNA Based Therapeutic Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 5.3. North America RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • 5.4. North America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.5. North America RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • 5.6. North America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.7. North America RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • 5.8. North America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.9. North America RNA Based Therapeutic Market Attractiveness Analysis, By Country
        • 5.9.1. The US
        • 5.9.2. Canada
    • 6. Europe RNA Based Therapeutic Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 6.3. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • 6.4. Europe RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.5. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • 6.6. Europe RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.7. Europe RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • 6.8. Europe RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.9. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Country
        • 6.9.1. Germany
        • 6.9.2. The UK
        • 6.9.3. France
        • 6.9.4. Spain
        • 6.9.5. Italy
        • 6.9.6. Russia
        • 6.9.7. Netherland
        • 6.9.8. Rest of Europe
    • 7. Asia Pacific RNA Based Therapeutic Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 7.3. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • 7.4. Asia Pacific RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.5. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • 7.6. Asia Pacific RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.7. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • 7.8. Asia Pacific RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.9. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Country
        • 7.9.1. China
        • 7.9.2. Japan
        • 7.9.3. South Korea
        • 7.9.4. India
        • 7.9.5. Australia
        • 7.9.6. New Zealand
        • 7.9.7. Singapore
        • 7.9.8. Thailand
        • 7.9.9. Vietnam
        • 7.9.10. Rest of Asia Pacific
    • 8. Latin America RNA Based Therapeutic Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 8.3. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • 8.4. Latin America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.5. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • 8.6. Latin America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.7. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • 8.8. Latin America RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.9. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Country
        • 8.9.1. Brazil
        • 8.9.2. Mexico
        • 8.9.3. Rest of Latin America
    • 9. Middle East & Africa RNA Based Therapeutic Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2020-2034
      • 9.3. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • 9.4. Middle East & Africa RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.5. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • 9.6. Middle East & Africa RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.7. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • 9.8. Middle East & Africa RNA Based Therapeutic Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.9. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Country
        • 9.9.1. South Africa
        • 9.9.2. Saudi Arabia
        • 9.9.3. UAE
        • 9.9.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
      • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
      • 10.7.1. Urban Therapeutics Inc
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
      • 10.7.2. Tekmira Pharmaceuticals Corp
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
      • 10.7.3. Silence Therapeutics PLC
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
      • 10.7.4. Pfizer
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
      • 10.7.5. Genzyme Corporation
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
      • 10.7.6. Dicerna Pharmaceuticals
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
      • 10.7.7. Benitec Biopharma Limited
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
      • 10.7.8. Alnylam Pharmaceuticals
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 2. Global RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 3. Global RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 4. Global RNA Based Therapeutic Market Value (US$ Mn), By Region, 2020-2034
      • Table 5. North America RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 6. North America RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 7. North America RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 8. North America RNA Based Therapeutic Market Value (US$ Mn), By Country, 2020-2034
      • Table 9. The US RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 10. The US RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 11. The US RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 12. Canada RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 13. Canada RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 14. Canada RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Europe RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 16. Europe RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 17. Europe RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 18. Europe RNA Based Therapeutic Market Value (US$ Mn), By Country, 2020-2034
      • Table 19. Germany RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 20. Germany RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 21. Germany RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 22. The UK RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 23. The UK RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 24. The UK RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 25. France RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 26. France RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 27. France RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. Spain RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 29. Spain RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 30. Spain RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 31. Italy RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 32. Italy RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 33. Italy RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 34. Russia RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 35. Russia RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 36. Russia RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 37. Netherland RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 38. Netherland RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 39. Netherland RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Rest of Europe RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 41. Rest of Europe RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 42. Rest of Europe RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 43. Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 44. Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 45. Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 46. Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By Country, 2020-2034
      • Table 47. China RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 48. China RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 49. China RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 50. India RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 51. India RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 52. India RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 53. Japan RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 54. Japan RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 55. Japan RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. South Korea RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 57. South Korea RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 58. South Korea RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 59. Australia RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 60. Australia RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 61. Australia RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 62. New Zealand RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 63. New Zealand RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 64. New Zealand RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. Singapore RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 66. Singapore RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 67. Singapore RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 68. Thailand RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 69. Thailand RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 70. Thailand RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 71. Vietnam RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 72. Vietnam RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 73. Vietnam RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 74. Rest of Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 75. Rest of Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 76. Rest of Asia Pacific RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Latin America RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 78. Latin America RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 79. Latin America RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 80. Latin America RNA Based Therapeutic Market Value (US$ Mn), By Country, 2020-2034
      • Table 81. Brazil RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 82. Brazil RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 83. Brazil RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 84. Mexico RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 85. Mexico RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 86. Mexico RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 87. Rest of Latin America RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 88. Rest of Latin America RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 89. Rest of Latin America RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 90. Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 91. Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 92. Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By Country, 2020-2034
      • Table 94. South Africa RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 95. South Africa RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 96. South Africa RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Saudi Arabia RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 98. Saudi Arabia RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 99. Saudi Arabia RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 100. UAE RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 101. UAE RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 102. UAE RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
      • Table 103. Rest of Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By Type, 2020-2034
      • Table 104. Rest of Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By Application, 2020-2034
      • Table 105. Rest of Middle East & Africa RNA Based Therapeutic Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global RNA Based Therapeutic Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in RNA Based Therapeutic Market
      • Figure 5. Global RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 6. Global RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 7. Global RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 8. Global RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 9. Global RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 10. Global RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 11. Global RNA Based Therapeutic Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 12. Global RNA Based Therapeutic Market Attractiveness Analysis, By Region
      • Figure 13. North America RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 14. North America RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 15. North America RNA Based Therapeutic Market (US$ Mn), by RNA Antisense, 2020-2034
      • Figure 16. North America RNA Based Therapeutic Market (US$ Mn), by RNA Interference (RNAi) Technologies, 2020-2034
      • Figure 17. North America RNA Based Therapeutic Market (US$ Mn), by Purification, 2020-2034
      • Figure 18. North America RNA Based Therapeutic Market (US$ Mn), by Labeling, 2020-2034
      • Figure 19. North America RNA Based Therapeutic Market (US$ Mn), by Inhibition, 2020-2034
      • Figure 20. North America RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 21. North America RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 22. North America RNA Based Therapeutic Market (US$ Mn), by Genetic Disorders, 2020-2034
      • Figure 23. North America RNA Based Therapeutic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 24. North America RNA Based Therapeutic Market (US$ Mn), by Metabolic Disorders, 2020-2034
      • Figure 25. North America RNA Based Therapeutic Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 26. North America RNA Based Therapeutic Market (US$ Mn), by Auto-immune Disorders, 2020-2034
      • Figure 27. North America RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 28. North America RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 29. North America RNA Based Therapeutic Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 30. North America RNA Based Therapeutic Market (US$ Mn), by Hospitals & Clinics, 2020-2034
      • Figure 31. North America RNA Based Therapeutic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 32. North America RNA Based Therapeutic Market Attractiveness Analysis, By Country
      • Figure 33. Europe RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 34. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 35. Europe RNA Based Therapeutic Market (US$ Mn), by RNA Antisense, 2020-2034
      • Figure 36. Europe RNA Based Therapeutic Market (US$ Mn), by RNA Interference (RNAi) Technologies, 2020-2034
      • Figure 37. Europe RNA Based Therapeutic Market (US$ Mn), by Purification, 2020-2034
      • Figure 38. Europe RNA Based Therapeutic Market (US$ Mn), by Labeling, 2020-2034
      • Figure 39. Europe RNA Based Therapeutic Market (US$ Mn), by Inhibition, 2020-2034
      • Figure 40. Europe RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 41. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 42. Europe RNA Based Therapeutic Market (US$ Mn), by Genetic Disorders, 2020-2034
      • Figure 43. Europe RNA Based Therapeutic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 44. Europe RNA Based Therapeutic Market (US$ Mn), by Metabolic Disorders, 2020-2034
      • Figure 45. Europe RNA Based Therapeutic Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 46. Europe RNA Based Therapeutic Market (US$ Mn), by Auto-immune Disorders, 2020-2034
      • Figure 47. Europe RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 48. Europe RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 49. Europe RNA Based Therapeutic Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 50. Europe RNA Based Therapeutic Market (US$ Mn), by Hospitals & Clinics, 2020-2034
      • Figure 51. Europe RNA Based Therapeutic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 52. Europe RNA Based Therapeutic Market Attractiveness Analysis, By Country
      • Figure 53. Asia Pacific RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 54. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 55. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by RNA Antisense, 2020-2034
      • Figure 56. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by RNA Interference (RNAi) Technologies, 2020-2034
      • Figure 57. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Purification, 2020-2034
      • Figure 58. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Labeling, 2020-2034
      • Figure 59. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Inhibition, 2020-2034
      • Figure 60. Asia Pacific RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 61. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 62. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Genetic Disorders, 2020-2034
      • Figure 63. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 64. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Metabolic Disorders, 2020-2034
      • Figure 65. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 66. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Auto-immune Disorders, 2020-2034
      • Figure 67. Asia Pacific RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 68. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 69. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 70. Asia Pacific RNA Based Therapeutic Market (US$ Mn), by Hospitals & Clinics, 2020-2034
      • Figure 71. Asia Pacific RNA Based Therapeutic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 72. Asia Pacific RNA Based Therapeutic Market Attractiveness Analysis, By Country
      • Figure 73. Latin America RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 74. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 75. Latin America RNA Based Therapeutic Market (US$ Mn), by RNA Antisense, 2020-2034
      • Figure 76. Latin America RNA Based Therapeutic Market (US$ Mn), by RNA Interference (RNAi) Technologies, 2020-2034
      • Figure 77. Latin America RNA Based Therapeutic Market (US$ Mn), by Purification, 2020-2034
      • Figure 78. Latin America RNA Based Therapeutic Market (US$ Mn), by Labeling, 2020-2034
      • Figure 79. Latin America RNA Based Therapeutic Market (US$ Mn), by Inhibition, 2020-2034
      • Figure 80. Latin America RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 81. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 82. Latin America RNA Based Therapeutic Market (US$ Mn), by Genetic Disorders, 2020-2034
      • Figure 83. Latin America RNA Based Therapeutic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 84. Latin America RNA Based Therapeutic Market (US$ Mn), by Metabolic Disorders, 2020-2034
      • Figure 85. Latin America RNA Based Therapeutic Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 86. Latin America RNA Based Therapeutic Market (US$ Mn), by Auto-immune Disorders, 2020-2034
      • Figure 87. Latin America RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 88. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 89. Latin America RNA Based Therapeutic Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 90. Latin America RNA Based Therapeutic Market (US$ Mn), by Hospitals & Clinics, 2020-2034
      • Figure 91. Latin America RNA Based Therapeutic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 92. Latin America RNA Based Therapeutic Market Attractiveness Analysis, By Country
      • Figure 93. Middle East & Africa RNA Based Therapeutic Market Analysis, By Type, 2020, 2024 and 2034
      • Figure 94. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Type
      • Figure 95. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by RNA Antisense, 2020-2034
      • Figure 96. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by RNA Interference (RNAi) Technologies, 2020-2034
      • Figure 97. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Purification, 2020-2034
      • Figure 98. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Labeling, 2020-2034
      • Figure 99. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Inhibition, 2020-2034
      • Figure 100. Middle East & Africa RNA Based Therapeutic Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 101. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Application
      • Figure 102. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Genetic Disorders, 2020-2034
      • Figure 103. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Oncology, 2020-2034
      • Figure 104. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Metabolic Disorders, 2020-2034
      • Figure 105. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 106. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Auto-immune Disorders, 2020-2034
      • Figure 107. Middle East & Africa RNA Based Therapeutic Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 108. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By End-user
      • Figure 109. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Research Institutes, 2020-2034
      • Figure 110. Middle East & Africa RNA Based Therapeutic Market (US$ Mn), by Hospitals & Clinics, 2020-2034
      • Figure 111. Middle East & Africa RNA Based Therapeutic Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 112. Middle East & Africa RNA Based Therapeutic Market Attractiveness Analysis, By Country
    • Urban Therapeutics Inc
    • Tekmira Pharmaceuticals Corp
    • Silence Therapeutics PLC
    • Pfizer Inc Company Profile
    • Genzyme Corporation
    • Dicerna Pharmaceuticals
    • Benitec Biopharma Limited
    • Alnylam Pharmaceuticals
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

RNA Based Therapeutic Market
  • 151331
  • June 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options